CBD may have strong benefits – but does it need help from other cannabinoids? The question is one of the hottest topics in cannabis as extractors see the markets shifting for different kinds of extracts. Beauty retailing behemoth Sephora announced earlier this year that it would stock only full- or broad-spectrum CBD products. Some cheered, […]
Read More
EMAIL: [email protected]
PHONE: 720.643.4450
PHONE: 720.643.4450
Neptune losses widen, even as revenue ticks up
Neptune Wellness Solutions, a Laval, Quebec-based CBD extractor and manufacturer, reported revenue of $16 million (CAD $21.4 million) for the fiscal quarter ended June 30, up 390% from the same period a year ago.
Read More
Tilray revenue hit by lower recreational, medical cannabis sales
Nanaimo, British Columbia-based Tilray halved its net loss to $81.7 million for the second quarter ended June 30, a substantial improvement over the previous quarter’s $184.1 million deficit. However, the cannabis and hemp producer reported lower sequential revenue in most of its important categories. Tilray trades as TLRY on the Nasdaq and reports in U.S. […]
Read More
Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact
United Kingdom-based GW Pharmaceuticals posted marginal revenue growth in the second quarter over the previous quarter, citing challenges stemming from the COVID-19 pandemic.
Read More
Editor’s Notebook: Federal CBD inaction forcing industry to self-regulate to fight illicit competitors
It isn’t just the guys and gals making high-THC products who confront illicit competition. Hemp entrepreneurs see it, too.
Read More
FDA approves GW Pharmaceuticals’ CBD drug for new indication
CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived medication.
Read More
Fees changing for foreign temporary labor visas
Hemp businesses using temporary foreign workers are going to see changing fee schedules for visas starting this fall.
Read More
Chart: 2020 an ‘extinction event’ for thousands of CBD companies, but industry remains crowded
Thousands of CBD companies in the United States will likely shutter in 2020 – but the CBD market will remain flooded with some 1,500 brands jostling for market share.
Read More
EPA funding hemp-pulping research in California
A project to make the process of extracting cellulose fibers from hemp more sustainable is getting a fresh round of funding from the U.S. Environmental Protection Agency.
Read More
Clock ticking on two USDA grant opportunities for hemp growers
For hemp businesses operating in compliance with U.S. Department of Agriculture-approved plans, there are a wealth of resources, large and small, that can easily fly under the radar.
Read More
Peru opens the door to CBD medicines, with commercialization imminent
Peru is giving hemp-derived medicines the green light, with commercialization imminent once the respective companies obtain the necessary import permits.
Read More
Odor complaints sparking talk of new ordinances in Colorado
Colorado officials who have long since settled how to zone marijuana cultivation to address odor complaints are starting to turn their sights to the hemp industry.
Read More